Archive: 13/02/2017

Lawmakers question pricing of drug for genetic disease

Marathon Pharmaceuticals' pricing of a drug to treat genetic muscle deterioration in about 15,000 Americans, mostly boys, is raising concerns in Congress where lawmakers repeatedly have challenged drug companies.

page 3 from 10